Study of TriClip treatment for severe leaky tricuspid valve
Part of Heart & circulation clinical trials.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe tricuspid valve leakage (regurgitation).
- You still feel symptoms even though you’re taking heart medicines (medical therapy).
- Your care team says you are eligible for the TriClip procedure.
- You can sign a written consent form before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a less invasive tricuspid valve repair or replacement can protect kidney function and improve physical activity in older adults with severe tricuspid valve leakage.
This study is testing whether the TriClip device helps people with severe tricuspid regurgitation (a leaky heart valve) feel better. It compares people who received the TriClip to those who didn't get the procedure.
This trial tests a procedure that uses a small clip to fix a leaky tricuspid valve in the heart. The goal is to reduce symptoms like shortness of breath and fatigue, and help you feel better in your daily life.
This study tests a clip device to fix a leaky tricuspid valve without open-heart surgery. It may help people who have symptoms like breathlessness or swelling and are not good candidates for surgery.
This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.